201 related articles for article (PubMed ID: 27091471)
1. Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.
Narita A; Kojima S
Int J Hematol; 2016 Aug; 104(2):153-8. PubMed ID: 27091471
[TBL] [Abstract][Full Text] [Related]
2. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
[TBL] [Abstract][Full Text] [Related]
3. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
Scheinberg P
Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
[TBL] [Abstract][Full Text] [Related]
4. Updated Guidelines for the Treatment of Acquired Aplastic Anemia in Children.
Yoshida N; Kojima S
Curr Oncol Rep; 2018 Jun; 20(9):67. PubMed ID: 29961134
[TBL] [Abstract][Full Text] [Related]
5. Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.
Li J; Zong SY; Yin ZX; Gao YY; Liu LP; Wan Y; Lan Y; Gong XW; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):303-308. PubMed ID: 35351262
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
[TBL] [Abstract][Full Text] [Related]
7. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J
Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884
[TBL] [Abstract][Full Text] [Related]
8. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia.
Yoshida N; Yagasaki H; Takahashi Y; Yamamoto T; Liang J; Wang Y; Tanaka M; Hama A; Nishio N; Kobayashi R; Hotta N; Asami K; Kikuta A; Fukushima T; Hirano N; Kojima S
Br J Haematol; 2008 Jul; 142(3):427-35. PubMed ID: 18537977
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of pre-treatment paroxysmal nocturnal hemoglobinuria clone on response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis.
Wang B; He B; Zhu YD; Wu W
Hematology; 2020 Dec; 25(1):464-472. PubMed ID: 33269994
[TBL] [Abstract][Full Text] [Related]
12. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
Kook H; Chung NG; Kang HJ; Im HJ
Int J Hematol; 2016 Apr; 103(4):380-6. PubMed ID: 26894608
[TBL] [Abstract][Full Text] [Related]
13. Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis.
Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
BMC Immunol; 2020 Mar; 21(1):10. PubMed ID: 32138642
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S; Pagliuca S; Risitano AM
Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
[TBL] [Abstract][Full Text] [Related]
15. Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia.
Tutelman PR; Aubert G; Milner RA; Dalal BI; Schultz KR; Deyell RJ
Br J Haematol; 2014 Mar; 164(5):717-21. PubMed ID: 24236830
[TBL] [Abstract][Full Text] [Related]
16. Acquired aplastic anemia in childhood.
Guinan EC
Hematol Oncol Clin North Am; 2009 Apr; 23(2):171-91. PubMed ID: 19327578
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of children with aplastic anemia.
Kurre P; Johnson FL; Deeg HJ
Pediatr Blood Cancer; 2005 Nov; 45(6):770-80. PubMed ID: 15706582
[TBL] [Abstract][Full Text] [Related]
18. Small PNH clones detected by fluorescent aerolysin predict a faster response to immunosuppressive therapy in patients with severe aplastic anaemia.
Ren X; Li X; Huo J; You Y; Huang J; Shao Y; Ge M; Huang Z; Zhang J; Wang M; Jin P; Nie N; Zheng Y
Hematology; 2020 Dec; 25(1):348-355. PubMed ID: 32960154
[No Abstract] [Full Text] [Related]
19. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia.
Deyell RJ; Shereck EB; Milner RA; Schultz KR
Pediatr Hematol Oncol; 2011 Sep; 28(6):469-78. PubMed ID: 21707222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
